Big setback for Merck cholesterol drug High doses of Zocor provide no benefits in preventing new problems in heart attack patients: study. MUNICH (Reuters) - Merck #39;s anti-cholesterol drug Zocor suffered a setback after a major study found high  

Which of the following sections of a newspaper would this article likely appear in? World News, Sports, Business, or Science and Technology? 